Related Experiment Video
Updated: Jun 6, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
A policy approach to the development of molecular diagnostic tests
Kevin A Schulman1, Sean R Tunis
1Duke Clinical Research Institute, Duke University School of Medicine and the Health Sector Management Program, The Fuqua School of Business, Duke University, Durham, North Carolina, USA. kevin.schulman@duke.edu
Abstract:
Efficiently generating evidence of clinical utility is a major challenge for ensuring clinical adoption of valuable diagnostics. A new approach to reimbursement in the United States offers a balance between evidence and incentives for molecular diagnostic tests.
Related Concept Videos
Modern Molecular Taxonomy
Automated Microbial Diagnostics
Rapid Identification of Pathogens
DNA Microarrays

